Clinical trial
A Pharmacokinetic Study of L-697,661 Alone and in Combination With Zidovudine
NCT00000628 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00000628 |
|---|---|
| Title | A Pharmacokinetic Study of L-697,661 Alone and in Combination With Zidovudine |
| Official title | A Pharmacokinetic Study of L-697,661 Alone and in Combination With Zidovudine |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Collaborators | National Institute of Allergy and Infectious Diseases (NIAID) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | L-697, 661, Zidovudine |
| Enrollment | 27 |
| First posted | Aug 31, 2001 |
| Last update posted | Jul 30, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: